These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 11533236

  • 1. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
    Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW.
    Mol Cell Biol; 2001 Oct; 21(19):6470-83. PubMed ID: 11533236
    [Abstract] [Full Text] [Related]

  • 2. Multiple regions of ETO cooperate in transcriptional repression.
    Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB.
    J Biol Chem; 2001 Mar 30; 276(13):9889-95. PubMed ID: 11150306
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.
    Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D, Hou Y.
    Cancer Chemother Pharmacol; 2001 Aug 30; 48 Suppl 1():S31-4. PubMed ID: 11587363
    [Abstract] [Full Text] [Related]

  • 4. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.
    Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW.
    Mol Cell Biol; 1998 Dec 30; 18(12):7176-84. PubMed ID: 9819404
    [Abstract] [Full Text] [Related]

  • 5. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
    Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM.
    Proc Natl Acad Sci U S A; 1998 Sep 01; 95(18):10860-5. PubMed ID: 9724795
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR.
    Olsson A, Olsson I, Dhanda RS.
    Biochim Biophys Acta; 2008 Oct 01; 1779(10):590-8. PubMed ID: 18586123
    [Abstract] [Full Text] [Related]

  • 7. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
    Deltour S, Guerardel C, Leprince D.
    Proc Natl Acad Sci U S A; 1999 Dec 21; 96(26):14831-6. PubMed ID: 10611298
    [Abstract] [Full Text] [Related]

  • 8. ETO interacting proteins.
    Hug BA, Lazar MA.
    Oncogene; 2004 May 24; 23(24):4270-4. PubMed ID: 15156183
    [Abstract] [Full Text] [Related]

  • 9. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.
    Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA.
    Mol Cell Biol; 1998 Dec 24; 18(12):7185-91. PubMed ID: 9819405
    [Abstract] [Full Text] [Related]

  • 10. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism.
    McGhee L, Bryan J, Elliott L, Grimes HL, Kazanjian A, Davis JN, Meyers S.
    J Cell Biochem; 2003 Aug 01; 89(5):1005-18. PubMed ID: 12874834
    [Abstract] [Full Text] [Related]

  • 11. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD.
    Blood; 2000 Dec 01; 96(12):3939-47. PubMed ID: 11090081
    [Abstract] [Full Text] [Related]

  • 12. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice.
    Grisolano JL, O'Neal J, Cain J, Tomasson MH.
    Proc Natl Acad Sci U S A; 2003 Aug 05; 100(16):9506-11. PubMed ID: 12881486
    [Abstract] [Full Text] [Related]

  • 13. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.
    Durst KL, Lutterbach B, Kummalue T, Friedman AD, Hiebert SW.
    Mol Cell Biol; 2003 Jan 05; 23(2):607-19. PubMed ID: 12509458
    [Abstract] [Full Text] [Related]

  • 14. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E, Greer SF, Zhu XS, Ting JP.
    Mol Cell Biol; 2003 May 05; 23(9):3091-102. PubMed ID: 12697811
    [Abstract] [Full Text] [Related]

  • 15. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.
    Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O.
    Nucleic Acids Res; 1998 Oct 15; 26(20):4645-51. PubMed ID: 9753732
    [Abstract] [Full Text] [Related]

  • 16. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.
    Lausen J, Cho S, Liu S, Werner MH.
    J Biol Chem; 2004 Nov 19; 279(47):49281-8. PubMed ID: 15377655
    [Abstract] [Full Text] [Related]

  • 17. Oligomerization of ETO is obligatory for corepressor interaction.
    Zhang J, Hug BA, Huang EY, Chen CW, Gelmetti V, Maccarana M, Minucci S, Pelicci PG, Lazar MA.
    Mol Cell Biol; 2001 Jan 19; 21(1):156-63. PubMed ID: 11113190
    [Abstract] [Full Text] [Related]

  • 18. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.
    Ibañez V, Sharma A, Buonamici S, Verma A, Kalakonda S, Wang J, Kadkol S, Saunthararajah Y.
    Cancer Res; 2004 Jul 01; 64(13):4547-54. PubMed ID: 15231665
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The ETO (MTG8) gene family.
    Davis JN, McGhee L, Meyers S.
    Gene; 2003 Jan 16; 303():1-10. PubMed ID: 12559562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.